Carcinoma  >>  goserelin acetate  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
NCT00849082: Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer

Completed
3
US
cyproterone acetate, goserelin acetate, radiation therapy
European Organisation for Research and Treatment of Cancer - EORTC
Prostate Cancer
11/95
 
NCT01394263: Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Completed
3
59
NA
Histrelin hydrogel implant, Vantas, Zoladex goserelin implant, Zoladex
Endo Pharmaceuticals
Prostate Cancer, Adenocarcinoma of the Prostate
12/01
12/03
NCT00767286: Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Completed
3
US
flutamide, goserelin acetate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy
Radiation Therapy Oncology Group, National Cancer Institute (NCI)
Prostate Cancer
 
11/03
NCT00021450: Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Completed
3
819
Europe, RoW
bicalutamide, goserelin acetate, adjuvant therapy, radiation therapy
European Organisation for Research and Treatment of Cancer - EORTC
Prostate Cancer
04/08
01/16
SHPD002, NCT02221999: Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

Active, not recruiting
2/3
250
RoW
Paclitaxel, Taxol, Cisplatin, Gonadotropin-releasing hormone agonist, Letrozole
RenJi Hospital
Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
01/19
01/29

Download Options